Bay Bioanalytical Laboratory Provides Biomarker Support to Successful…

BBL, recently acquired by Pacific BioLabs, contributed to a successful orphan drug Phase 3 trial of BioMarin's GALNS for Morquio Syndrome.

(PRWeb January 28, 2013)

Read the full story at

Comments are closed.

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.